Skip to main content

Unable to load price data. Sorry.


Power 3 Medical Products Inc. (NASDAQOTCBB:PWRM)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
1 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQOTCBB:PWRM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

TMFStockSpam (27.68)
Submitted May 18, 2010

This stock spam was originally sent to TMFBent:PWRM, Power 3 Medical Products Inc., PWRM.OBPWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such… More


Fools bullish on NASDAQOTCBB:PWRM are also bullish on:

Fools bearish on NASDAQOTCBB:PWRM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PWRM.


Member Avatar TMFStockSpam (27.68) Submitted: 5/18/2010 12:17:06 AM : Underperform Start Price: $0.05 NASDAQ OTC:PWRM Score: +342.23

This stock spam was originally sent to TMFBent:

PWRM, Power 3 Medical Products Inc., PWRM.OB

PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, PWRM has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, currently engaged in Phase II clinical trials. These products are designed to analyze proteins and their mutations to assess an individual's risk for developing disease later in life, a patient's likelihood of responding to a particular drug, a patient's risk of disease progression and disease recurrence, to measure a patient's exposure to drug therapy, to ensure optimal dosing and reduced drug toxicity.

** HOT NEWS OUT: PWRM has filed two provisional patent applications **

PWRM that it has filed two provisional patent applications with the United States Patent and Trademark Office (USPTO) - one on Alzheimer's disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer's disease patients.

These two provisional patent applications, along with the additional provisional patent application recently filed by the principals ofPWRM and others (Business Wire, May 4, 2010) on the use of stem cell protein biomarkers to monitor stem cell therapy and three other recently filed provisional patent applications on Parkinson's and Alzheimer's disease diagnosis, disclose a vast amount of invaluable information crucial to the accurate diagnosis and treatment of neurodegenerative diseases.

These provisional patent applications cover diagnosis, treatment options and therapy monitoring in neurodegenerative diseases. The combination of these disclosures forms a strong foundation for innovation in diagnosis and treatment for Alzheimer's disease, and other diseases, through the genome and proteome of the patient, i.e., Personalized Regenerative Medicine (PRM)

What are you waiting for? You are on time to include PWRM on your watch list!

PWRM's trading levels could change in no time and you don't want to be out of the action!!

More about PWRM at

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)


Find the members with the highest scoring picks in PWRM.

Score Leader


TMFStockSpam (27.68) Score: +342.23

The Score Leader is the player with the highest score across all their picks in PWRM.

Member Name Member
Call Time
Score Commentary
TMFStockSpam 27.68 5/17/2010 Underperform NS $0.05 -97.20% +245.03% +342.23 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PWRM.